Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function - Kielgast, Urd; Holst, Jens J.; Madsbad, Sten (Diabetes (New York, N.Y.), 2011)
Keywords: Adult; Biological and medical sciences; Blood Glucose - drug effects; C-Peptide - blood; Comparative analysis; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - drug therapy; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; Gastric Emptying - drug effects; Gastric Inhibitory Polypeptide; Gastrointestinal hormones; Glucagon - blood; Glucagon-Like Peptide 1 - administration & dosage; Glucagon-Like Peptide 1 - therapeutic use; Health aspects; Hemodialysis patients; Humans; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - therapeutic use; Insulin - pharmacology; Insulin-Secreting Cells - drug effects; Male; Medical sciences; Peptide Fragments - pharmacology; Peptide Fragments - therapeutic use; Peptides; Pharmacology and Therapeutics; Physiological aspects; Triglycerides - blood; Young Adult; Denmark; Endocrinopathy; Human; Immunopathology; Type 1 diabetes; Langerhans islet; Autoimmune disease; β Cell; Endocrine pancreas